Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735

Seeking Alpha32minutes ago

novo-nordisk a/s (NVO.US) has signed a contract with Ypsomed to produce the next generation of injection pens for weight loss medication.

novo-nordisk a/s has announced that it has signed a contract with Ypsomed to produce the next generation of weight loss pen.

Zhitong Finance08:30 ET

Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens

Seeking Alpha07:31 ET

Amgen (AMGN.US) weight loss drug is poised to launch, and Wall Street is eagerly awaiting the research results.

Amgen (AMGN.US) will soon release mid-term study data for the experimental weight loss drug MariTide, revealing a comparison of this drug with GLP-1 drugs from Eli Lilly (LLY.US) and novo-nordisk A/S (NVO.US).

Zhitong Finance04:02 ET

In 2025, the global medical care industry is expected to usher in an investment boom, with a focus on Biotech.

Jefferies financial indicated that investor sentiment in the global medical care industry has significantly warmed up.

Zhitong Finance20:21 ET

Optimism Over Global Healthcare Sector Rises: Jefferies

Seeking Alpha13:45 ET